A responsible drug ad points out the difference between Amaryl and Reminyl

I can give props when it’s due. I saw this ad today in Internal Medicine News (ok, not really directed at consumers). But for once, it has some redeemable qualities, alerting readers about the potential for prescribing errors between Amaryl and Reminyl.

Related posts:

1. Drug companies responsible for generic side effects?
2. The waning effect of direct to consumer drug advertising
3. Academia responsible for the primary care shortage?
4. Who is responsible for an abnormality on pre-operative testing, or, aren’t radiologists doctors too?
5. Is the doctor or patient responsible for celebrity drug overdoses?
6. The difference between competency and capacity
7. Does e-prescribing save prescription drug costs?

  Follow on Twitter   Subscribe